Skip to main content

Table 1 Patient demographics and general characteristics per age-at-onset subgroup

From: Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database

 

Neonatal onset (N = 6)

Early infantile onset (N = 8)

Late-infantile onset (N = 51)

Juvenile onset (N = 42)

Adolescent/adult onset (N = 25)

Gender, n (%) female

3 (50)

7 (88)

28 (55)

25 (60)

10 (40)

Age, years:

     

At neurological onset

     

 na

–

8

50

40

18

 Mean (SD)

–

1.1 (0.7)

4.1 (1.2)

9.4 (2.6)

24.2 (8.8)

At diagnosis

     

 na

4c

7c

49

39

24

 Mean (SD)

0.1 (0.1)

1.3 (1.5)

4.6 (5.5)

11.5 (7.4)

29.3 (9.3)

At last follow upb

     

 na

–

–

19

21

17

 Mean (SD)

–

–

11.6 (8.9)

20.2 (9.0)

39.5 (9.2)

At death

     

 na

6

8

30

19

8

 Mean (SD)

0.19 (0.22)

5.6 (2.0)

13.4 (6.7)

25.9 (8.9)

33.7 (6.2)

Number (%)d with NP-C genetic information

1 (17)

8 (100)

41 (80)

36 (86)

16 (64)

Number (%)d treated with miglustat

–

2 (25)

17 (33)

20 (48)

12 (48)

  1. aNumber of patients with available data; blast follow up (data cut-off at end-2011) in living patients only; cage at diagnosis not relevant for two neonatal patients and one early-infantile patient who were diagnosed post-mortem; dpercentages calculated relative to total number of patients per treatment subgroup